Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study

The cardiovascular safety of tiotropium Respimat formulation in the routine clinical practice is still an open issue. Our aim was to compare the risk of acute myocardial infarction and heart rhythm disorders in incident users of either tiotropium Respimat or HandiHaler. The study population comprise...

Descripción completa

Detalles Bibliográficos
Autores principales: Trotta, Francesco, Spila-Alegiani, Stefania, Da Cas, Roberto, Rajevic, Maja, Conti, Valentino, Venegoni, Mauro, Rossi, Mariangela, Traversa, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400270/
https://www.ncbi.nlm.nih.gov/pubmed/28430820
http://dx.doi.org/10.1371/journal.pone.0176276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400270/
https://www.ncbi.nlm.nih.gov/pubmed/28430820
http://dx.doi.org/10.1371/journal.pone.0176276

Ejemplares similares